U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    FSTL1 follistatin like 1 [ Homo sapiens (human) ]

    Gene ID: 11167, updated on 3-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    A site-specific phosphorylation in FSTL1 determines its promigratory role in wound healing.

    A site-specific phosphorylation in FSTL1 determines its promigratory role in wound healing.
    Suresh AP, Vijayarengan M, Aggarwal P, Soundaram R, Gnanesh Kumar BS, Sundaram GM.

    09/23/2024
    THOC7-AS1/OCT1/FSTL1 axis promotes EMT and serves as a therapeutic target in cutaneous squamous cell carcinoma.

    THOC7-AS1/OCT1/FSTL1 axis promotes EMT and serves as a therapeutic target in cutaneous squamous cell carcinoma.
    Yu S, Cui X, Zhou S, Li Y, Feng W, Zhang X, Zhong Y, Zhang P., Free PMC Article

    04/29/2024
    FSTL1: A double-edged sword in cancer development.

    FSTL1: A double-edged sword in cancer development.
    Du R, Li K, Guo K, Chen Z, Han L, Bian H.

    03/11/2024
    Follistatin-like 1 is a myokine regulating lipid mobilization during endurance exercise and recovery.

    Follistatin-like 1 is a myokine regulating lipid mobilization during endurance exercise and recovery.
    Nam JS, Park SJ, Ahn CW, Cho ES, Kim HJ, Kim Y.

    02/5/2024
    Analysis of the expression and mechanism of follistatin-like protein 1 in cervical cancer.

    Analysis of the expression and mechanism of follistatin‑like protein 1 in cervical cancer.
    Liu Z, Zhang H, Hu X., Free PMC Article

    11/7/2023
    Role of follistatin-like protein 1 in liver diseases.

    Role of follistatin-like protein 1 in liver diseases.
    Gu C, Xue H, Yang X, Nie Y, Qian X., Free PMC Article

    04/14/2023
    CircPTTG1IP knockdown suppresses rheumatoid arthritis progression by targeting miR-431-5p/FSTL1 axis.

    CircPTTG1IP knockdown suppresses rheumatoid arthritis progression by targeting miR-431-5p/FSTL1 axis.
    Yang C, Liu Q, Jiang Z.

    12/3/2022
    FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2.

    FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2.
    Rao J, Wang H, Ni M, Wang Z, Wang Z, Wei S, Liu M, Wang P, Qiu J, Zhang L, Wu C, Shen H, Wang X, Cheng F, Lu L., Free PMC Article

    11/12/2022
    FOXO1 inhibits FSL-1 regulation of integrin beta6 by blocking STAT3 binding to the integrin beta6 gene promoter.

    FOXO1 inhibits FSL-1 regulation of integrin β6 by blocking STAT3 binding to the integrin β6 gene promoter.
    Xu M, Huang J, Zhu F, Shen K, Liu F, Deng X., Free PMC Article

    11/5/2022
    Follistatin-like 1 and its paralogs in heart development and cardiovascular disease.

    Follistatin-like 1 and its paralogs in heart development and cardiovascular disease.
    Horak M, Fairweather D, Kokkonen P, Bednar D, Bienertova-Vasku J., Free PMC Article

    10/15/2022
    Effects of acute endurance exercise on follistatin-like 1 and apelin in the circulation and metabolic organs in rats.

    Effects of acute endurance exercise on follistatin-like 1 and apelin in the circulation and metabolic organs in rats.
    Kon M, Tanimura Y, Yoshizato H.

    10/8/2022
    Odd-skipped related 1 plays a tumor suppressor role in ovarian cancer via promoting follistatin-like protein 1 transcription.

    Odd-skipped related 1 plays a tumor suppressor role in ovarian cancer via promoting follistatin-like protein 1 transcription.
    Yu Z, Ouyang L.

    10/8/2022
    Follistatin-Like 1 and Family with Sequence Similarity to 19 Member A5 Levels Are Decreased in Obese Children and Associated with Glucose Metabolism.

    Follistatin-Like 1 and Family with Sequence Similarity to 19 Member A5 Levels Are Decreased in Obese Children and Associated with Glucose Metabolism.
    Xie K, Liu L, Yin C, Li M, Wang L, Lv W, Chang Y, Xiao Y.

    08/27/2022
    Follistatin-like 1 (FSTL1) interacts with Wnt ligands and Frizzled receptors to enhance Wnt/beta-catenin signaling in obstructed kidneys in vivo.

    Follistatin-like 1 (FSTL1) interacts with Wnt ligands and Frizzled receptors to enhance Wnt/β-catenin signaling in obstructed kidneys in vivo.
    Zhang Y, Wang Y, Zheng G, Liu Y, Li J, Huang H, Xu C, Zeng Y, Zhang X, Qin J, Dai C, Hambrock HO, Hartmann U, Feng B, Mak KK, Liu Y, Lan HY, Huang Y, Zheng ZH, Xia Y., Free PMC Article

    07/30/2022
    Silencing of FSTL1 Alleviated LPS-Induced Inflammatory Damage and Oxidative Damage in Human Bronchial Epithelial Cells via BMP4/KLF4 Axis.

    Silencing of FSTL1 Alleviated LPS-Induced Inflammatory Damage and Oxidative Damage in Human Bronchial Epithelial Cells via BMP4/KLF4 Axis.
    Zhang Y, Yan L, Yang J, Li X.

    07/9/2022
    Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly.

    Specific FSTL1 polymorphism may determine the risk of cardiomyopathy in patients with acromegaly.
    Sendur SN, Hazirolan T, Aydin B, Lay I, Alikasifoglu M, Erbas T.

    06/11/2022
    Hsa_circ_0058129 regulates papillary thyroid cancer development via miR-873-5p/follistatin-like 1 axis.

    Hsa_circ_0058129 regulates papillary thyroid cancer development via miR-873-5p/follistatin-like 1 axis.
    Tan X, Zhao J, Lou J, Zheng W, Wang P., Free PMC Article

    05/21/2022
    Changes of FSTL1 and MMP-9 levels in patients with acute cerebral infarction and its relationship with hemorrhagic transformation.

    Changes of FSTL1 and MMP-9 levels in patients with acute cerebral infarction and its relationship with hemorrhagic transformation.
    Ling C, Cao S, Kong X.

    05/7/2022
    Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma.

    Blocking FSTL1 boosts NK immunity in treatment of osteosarcoma.
    Ogiwara Y, Nakagawa M, Nakatani F, Uemura Y, Zhang R, Kudo-Saito C.

    05/7/2022
    Ups and downs: The PPARgamma/p-PPARgamma seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis.

    Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis.
    Fang D, Shi X, Jia X, Yang C, Wang L, Du B, Lu T, Shan L, Gao Y., Free PMC Article

    04/2/2022
    Follistatin-like I promotes endometriosis by increasing proinflammatory factors and promoting angiogenesis.

    Follistatin-like I promotes endometriosis by increasing proinflammatory factors and promoting angiogenesis.
    Lei ST, Li MQ, Cao YL, Hou SH, Peng HY, Zhao D, Sun J.

    04/2/2022
    Follistatin-related protein 1 interacting partner of Syndecan-1 promotes an aggressive phenotype on Oral Squamous cell carcinoma (OSCC) models.

    Follistatin-related protein 1 interacting partner of Syndecan-1 promotes an aggressive phenotype on Oral Squamous cell carcinoma (OSCC) models.
    Zandonadi FS, Yokoo S, Granato DC, Rivera C, Macedo CCS, Soares CD, Carnielli CM, Domingues RR, Pauletti BA, Consonni SR, Colleta RD, Paes Leme AF.

    03/5/2022
    TNF-alpha induces up-regulation of MicroRNA-27a via the P38 signalling pathway, which inhibits intervertebral disc degeneration by targeting FSTL1.

    TNF-α induces up-regulation of MicroRNA-27a via the P38 signalling pathway, which inhibits intervertebral disc degeneration by targeting FSTL1.
    Shi J, Wang S, He Q, Liu K, Zhao W, Xie Q, Cheng L., Free PMC Article

    02/5/2022
    FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness.

    FSTL1 Secreted by Activated Fibroblasts Promotes Hepatocellular Carcinoma Metastasis and Stemness.
    Loh JJ, Li TW, Zhou L, Wong TL, Liu X, Ma VWS, Lo CM, Man K, Lee TK, Ning W, Tong M, Ma S.

    01/15/2022
    Prognostic impact of transcardiac gradient of follistatin-like 1 reflecting hemodynamics in patients with dilated cardiomyopathy.

    Prognostic impact of transcardiac gradient of follistatin-like 1 reflecting hemodynamics in patients with dilated cardiomyopathy.
    Oishi H, Okumura T, Ohashi K, Kimura Y, Kazama S, Shibata N, Arao Y, Kato H, Kuwayama T, Yamaguchi S, Tatsumi M, Kondo T, Hiraiwa H, Morimoto R, Takefuji M, Ouchi N, Murohara T.

    01/15/2022
    firstprevious page of 5 nextlast